UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation

British journal of pharmacology, 2019-07, Vol.176 (13), p.2279-2291

2019

Volltextzugriff (PDF)

Microglial P2X4R-evoked pain hypersensitivity is sexually dimorphic in rats

Pain (Amsterdam), 2018-09, Vol.159 (9), p.1752-1763

2018

Volltextzugriff (PDF)

X-ray structures define human P2X(3) receptor gating cycle and antagonist action

Nature (London), 2016-10, Vol.538 (7623), p.66

2016

Volltextzugriff (PDF)

P2X7 receptor antagonism: Implications in diabetic retinopathy

Biochemical pharmacology, 2017-08, Vol.138, p.130-139

2017

Volltextzugriff (PDF)

P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases

European journal of pharmacology, 2021-09, Vol.906, p.174235-174235, Article 174235

2021

Volltextzugriff (PDF)

Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men

British journal of clinical pharmacology, 2024-08, Vol.90 (8), p.2004-2018

2024

Volltextzugriff (PDF)

P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia

Glia, 2014-04, Vol.62 (4), p.592-607

2014

Volltextzugriff (PDF)

Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke

Experimental neurology, 2020-07, Vol.329, p.113308-113308, Article 113308

2020

Volltextzugriff (PDF)

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

British journal of pharmacology, 2013-10, Vol.170 (3), p.624-640

2013

Volltextzugriff (PDF)

P2X receptors: Insights from the study of the domestic dog

Neuropharmacology, 2023-02, Vol.224, p.109358, Article 109358

2023

Volltextzugriff (PDF)

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment

Oncogene, 2019-05, Vol.38 (19), p.3636-3650

2019

Volltextzugriff (PDF)

Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?

Biochemical pharmacology, 2024-04, Vol.222, p.116046, Article 116046

2024

Volltextzugriff (PDF)

CD39 Limits P2X7 Receptor Inflammatory Signaling and Attenuates Sepsis-Induced Liver Injury

Journal of hepatology, 2017-10, Vol.67 (4), p.716-726

2017

Volltextzugriff (PDF)

Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and LL-37

European journal of pharmacology, 2022-01, Vol.914, p.174667-174667, Article 174667

2022

Volltextzugriff (PDF)

Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities

British journal of pharmacology, 2024-09, Vol.181 (17), p.3282-3299

2024

Volltextzugriff (PDF)

Purinergic P2X7 receptor as a potential therapeutic target in depression

Biochemical pharmacology, 2024-01, Vol.219, p.115959-115959, Article 115959

2024

Volltextzugriff (PDF)

How is the P2X7 receptor signaling pathway involved in epileptogenesis?

Neurochemistry international, 2024-02, Vol.173, p.105675-105675, Article 105675

2024

Volltextzugriff (PDF)

Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists

Biochemical pharmacology, 2016-09, Vol.116, p.130-139

2016

Volltextzugriff (PDF)

P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release

The FASEB journal, 2012-07, Vol.26 (7), p.2951-2962

2012

Volltextzugriff (PDF)

Liver kinase B1/AMP‐activated protein kinase‐mediated regulation by gentiopicroside ameliorates P2X7 receptor‐dependent alcoholic hepatosteatosis

British journal of pharmacology, 2018-05, Vol.175 (9), p.1451-1470

2018

Volltextzugriff (PDF)

Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice

The FASEB journal, 2012-04, Vol.26 (4), p.1616-1628

2012

Volltextzugriff (PDF)

The P2X7 receptor links mechanical strain to cytokine IL‐6 up‐regulation and release in neurons and astrocytes

Journal of neurochemistry, 2017-05, Vol.141 (3), p.436-448

2017

Volltextzugriff (PDF)

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

The Journal of pathology, 2022-02, Vol.256 (2), p.149-163

2022

Volltextzugriff (PDF)

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

Journal of psychopharmacology (Oxford), 2018-12, Vol.32 (12), p.1341-1350

2018

Volltextzugriff (PDF)

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Molecular neurobiology, 2024-05, Vol.61 (5), p.2866-2880

2024

Volltextzugriff (PDF)

1 – 25 von 365

Suche als RSS-Feed

Aktive Filter

KollektionRCN full-text journals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(364)
Mit Volltextzugriff
(347)

Publikationsform

Artikel
(365)

Sprache

Englisch
(365)

Erscheinungsjahr

n.n

Thema

Animals
(313)
Science & Technology
(288)
Life Sciences & Biomedicine
(287)
Male
(173)
Adenosine Triphosphate - Pharmacology
(169)
Purinergic P2x Receptor Antagonists - Pharmacology
(169)
Rats
(146)
Pharmacology & Pharmacy
(143)
Adenosine Triphosphate - Analogs & Derivatives
(125)
Humans
(125)
Biological And Medical Sciences
(115)
Neurosciences
(109)
Neurosciences & Neurology
(108)
Purinergic P2 Receptor Antagonists
(101)
Atp
(99)
Mice
(85)
Medical Sciences
(82)
Dose-Response Relationship, Drug
(81)
Receptors, Purinergic P2x7 - Metabolism
(79)
Adenosine Triphosphate - Metabolism
(75)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation

Microglial P2X4R-evoked pain hypersensitivity is sexually dimorphic in rats

X-ray structures define human P2X(3) receptor gating cycle and antagonist action

P2X7 receptor antagonism: Implications in diabetic retinopathy

P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases

Pharmacodynamics, pharmacokinetics and CYP3A4 interaction potential of the selective P2X3 receptor antagonist filapixant: A randomized multiple ascending‐dose study in healthy young men

P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia

Neuroprotective and neuro-rehabilitative effects of acute purinergic receptor P2X4 (P2X4R) blockade after ischemic stroke

Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ‐47965567

P2X receptors: Insights from the study of the domestic dog

The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment

Is there a biochemical basis for purinergic P2X3 and P2X4 receptor antagonists to be considered as anti-seizure medications?

CD39 Limits P2X7 Receptor Inflammatory Signaling and Attenuates Sepsis-Induced Liver Injury

Pharmacological characterization of a structural hybrid P2X7R antagonist using ATP and LL-37

Topical application of a P2X2/P2X3 purine receptor inhibitor suppresses the bitter taste of medicines and other taste qualities

Purinergic P2X7 receptor as a potential therapeutic target in depression

How is the P2X7 receptor signaling pathway involved in epileptogenesis?

Structure-based identification and characterisation of structurally novel human P2X7 receptor antagonists

P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release

Liver kinase B1/AMP‐activated protein kinase‐mediated regulation by gentiopicroside ameliorates P2X7 receptor‐dependent alcoholic hepatosteatosis

Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice

The P2X7 receptor links mechanical strain to cytokine IL‐6 up‐regulation and release in neurons and astrocytes

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants

P2X7 Receptor: an Emerging Target in Alzheimer’s Disease

Aktive Filter

Suchergebnisse filtern